Based on the above data, we disclosed DM is synergistically unfavourable to the survival outcome among patients with high expression of CEBPD by means of the aggressive tumour growth stemmed from the metabolic disorder of mTOR signalling and glycolysis. Here, MTOR is linked to diabetes mellitus.